During the past decade, Horizon Research Group, Inc conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 20 clinical trials were completed, i.e. on average, 666.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Horizon Research Group, Inc" #1 sponsor was "Pfizer" with 10 trials, followed by "Pacira Pharmaceuticals, Inc" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Teva Branded Pharmaceutical Products R&D, Inc." with 2 trials sponsored and "Abbott Nutrition" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Horizon Research Group, Inc" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Great Lakes Drug Development, Inc." with 1 trials as a collaborator, "Integrium" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Prosoft Clinical" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Horizon Research Group, Inc" are "Osteoarthritis" (5 trials), "Chronic Pain" (4 trials), "Psoriasis" (4 trials), "Low Back Pain" (3 trials) and "Pain" (3 trials). Many other conditions were trialed in "Horizon Research Group, Inc" in a lesser frequency.

Most popular intervention types in "Horizon Research Group, Inc" are "Drug" (22 trials), "Biological" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "CP-690,550" (2 trials), "Hydrocodone ER" (2 trials), "bupivacaine liposome injectable suspension" (2 trials) and "tanezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Horizon Research Group, Inc" are 25 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Horizon Research Group, Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Horizon Research Group, Inc, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Horizon Research Group, Inc, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".